Literature DB >> 20151216

Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas.

Sam S Yoon1, Yen-Lin Chen, David G Kirsch, Ugwuji N Maduekwe, Andrew E Rosenberg, G Petur Nielsen, Dushyant V Sahani, Edwin Choy, David C Harmon, Thomas F DeLaney.   

Abstract

BACKGROUND: We sought to reduce local recurrence for retroperitoneal sarcomas by using a coordinated strategy of advanced radiation techniques and aggressive en-bloc surgical resection.
METHODS: Proton-beam radiation therapy (PBRT) and/or intensity-modulated radiation therapy (IMRT) were delivered to improve tumor target coverage and spare selected adjacent organs. Surgical resection of tumor and adjacent organs was performed to obtain a disease-free anterior margin. Intraoperative electron radiation therapy (IOERT) was delivered to any close posterior margin.
RESULTS: Twenty patients had primary tumors and eight had recurrent tumors. Tumors were large (median size 9.75 cm), primarily liposarcomas and leiomyosarcomas (71%), and were mostly of intermediate or high grade (81%). PBRT and/or IMRT were delivered to all patients, preferably preoperatively (75%), to a median dose of 50 Gy. Surgical resection included up to five adjacent organs, most commonly the colon (n = 7) and kidney (n = 7). Margins were positive for disease, usually posteriorly, in 15 patients (54%). IOERT was delivered to the posterior margin in 12 patients (43%) to a median dose of 11 Gy. Surgical complications occurred in eight patients (28.6%), and radiation-related complications occurred in four patients (14%). After a median follow-up of 33 months, only two patients (10%) with primary disease experienced local recurrence, while three patients (37.5%) with recurrent disease experienced local recurrence.
CONCLUSIONS: Aggressive resection of retroperitoneal sarcomas can achieve a disease-negative anterior margin. PBRT and/or IMRT with IOERT may possibly deliver sufficient radiation dose to the posterior margin to control microscopic residual disease. This strategy may minimize radiation-related morbidity and reduce local recurrence, especially in patients with primary disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151216      PMCID: PMC2943833          DOI: 10.1245/s10434-010-0935-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  27 in total

1.  Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma.

Authors:  H L Gieschen; I J Spiro; H D Suit; M J Ott; D W Rattner; M Ancukiewicz; C G Willett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-05-01       Impact factor: 7.038

2.  Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.

Authors:  E Stoeckle; J M Coindre; S Bonvalot; G Kantor; P Terrier; F Bonichon; B Nguyen Bui
Journal:  Cancer       Date:  2001-07-15       Impact factor: 6.860

3.  Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas.

Authors:  Ivy A Petersen; Michael G Haddock; John H Donohue; David M Nagorney; Joseph P Grill; Daniel J Sargent; Leonard L Gunderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

4.  Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.

Authors:  Emad Youssef; James Fontanesi; Michael Mott; Michael Kraut; David Lucas; Hany Mekhael; Edgar Ben-Josef
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

5.  Significance of dose in postoperative radiotherapy for soft tissue sarcoma.

Authors:  Gunar K Zagars; Matthew T Ballo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

6.  Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.

Authors:  Alessandro Gronchi; Salvatore Lo Vullo; Marco Fiore; Chiara Mussi; Silvia Stacchiotti; Paola Collini; Laura Lozza; Elisabetta Pennacchioli; Luigi Mariani; Paolo Giovanni Casali
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

7.  Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.

Authors:  Sylvie Bonvalot; Michel Rivoire; Marine Castaing; Eberhard Stoeckle; Axel Le Cesne; Jean Yves Blay; Agnès Laplanche
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

8.  Radiation therapy for control of soft-tissue sarcomas resected with positive margins.

Authors:  Thomas F Delaney; Lucyna Kepka; Saveli I Goldberg; Francis J Hornicek; Mark C Gebhardt; Sam S Yoon; Dempsey S Springfield; Kevin A Raskin; David C Harmon; David G Kirsch; Henry J Mankin; Andrew E Rosenberg; G Petur Nielsen; Herman D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-01       Impact factor: 7.038

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 10.  The role of radiation in retroperitoneal sarcomas: a surgical perspective.

Authors:  Timothy M Pawlik; Nita Ahuja; Joseph M Herman
Journal:  Curr Opin Oncol       Date:  2007-07       Impact factor: 3.645

View more
  30 in total

1.  High-grade myxofibrosarcoma of the abdominal wall.

Authors:  Richard Antbring; Sam G Parker; Jeffrey T Lordan; Alastair Cj Windsor
Journal:  BMJ Case Rep       Date:  2017-06-02

Review 2.  Research opportunities in intraoperative radiation therapy: the next decade 2013-2023.

Authors:  F A Calvo; C V Sole; M E González; E D Tangco; J López-Tarjuelo; I Koubychine; J A Santos; J Pascau; R Herranz; C Ferrer
Journal:  Clin Transl Oncol       Date:  2013-03-05       Impact factor: 3.405

Review 3.  Radiation therapy for retroperitoneal sarcoma.

Authors:  Jeffrey Tuan; Viviana Vitolo; Barbara Vischioni; Alberto Iannalfi; Maria Rosaria Fiore; Piero Fossati; Roberto Orecchia
Journal:  Radiol Med       Date:  2014-03-18       Impact factor: 3.469

4.  Effect of intraoperative radiotherapy in the treatment of retroperitoneal sarcoma.

Authors:  Liz B Wang; David McAneny; Gerard Doherty; Teviah Sachs
Journal:  Int J Clin Oncol       Date:  2017-01-10       Impact factor: 3.402

Review 5.  Soft tissue sarcoma and radiation therapy advances, impact on toxicity.

Authors:  Nancy El-Bared; Philip Wong; Dian Wang
Journal:  Curr Treat Options Oncol       Date:  2015-05

6.  Texture Analysis of Non-Contrast-Enhanced Computed Tomography for Assessing Angiogenesis and Survival of Soft Tissue Sarcoma.

Authors:  Koichi Hayano; Fang Tian; Avinash R Kambadakone; Sam S Yoon; Dan G Duda; Balaji Ganeshan; Dushyant V Sahani
Journal:  J Comput Assist Tomogr       Date:  2015 Jul-Aug       Impact factor: 1.826

Review 7.  Surgical management of retroperitoneal and pelvic sarcomas.

Authors:  Marcus C B Tan; Sam S Yoon
Journal:  J Surg Oncol       Date:  2014-12-05       Impact factor: 3.454

8.  Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.

Authors:  Vivek Verma; Steven H Lin; Charles B Simone; Minesh P Mehta
Journal:  J Gastrointest Oncol       Date:  2016-08

9.  Intraoperative electron radiation therapy as an important treatment modality in retroperitoneal sarcoma.

Authors:  Raeshell S Sweeting; Allison M Deal; Omar H Llaguna; Brian K Bednarski; Michael O Meyers; Jen Jen Yeh; Benjamin F Calvo; Joel E Tepper; Hong Jin Kim
Journal:  J Surg Res       Date:  2013-05-29       Impact factor: 2.192

Review 10.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.